“…Subsequently, it was reported in Malaysia (Homonnay et al, 2014) and Thailand (Thontiravong et al, 2015). Since the emergence of the disease, different types of TMUV vaccine candidates have been developed in China, such as live-attenuated vaccines (Li et al, 2014;Wang et al, 2016;He et al, 2019;Huang et al, 2019;Zhang et al, 2020), inactivated vaccines (Lin et al, 2015;Zhang et al, 2017;Liu et al, 2018), subunit vaccines (Zhao et al, 2015;Ma et al, 2016), recombinant duck enteritis virus-, Newcastle disease virus-, and adenovirusvectored vaccines (Chen et al, 2014;Zou et al, 2014Zou et al, , 2017Sun et al, 2018;Tang et al, 2019), and DNA vaccines (Huang et al, 2018a,b;Tang et al, 2018). Among them, live-attenuated TMUV WFG36 (Wang et al, 2016) and FX2010 (Li et al, 2014) vaccines and inactivated TMUV HB vaccine (Liu et al, 2018) have been licensed to use in ducks in China.…”